Flavimax Overview

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Flavimax General Information


Developer of liposomal-antioxidant drugs designed to treat tissue regeneration and gestosis of pregnant women. The company's drugs are used in gynecology, perinatology, and for the prevention of premature birth, enabling patients to get the treatment quickly.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • Ulica Pobedy, 28
  • Reutov
  • Moscow, 143968
  • Russia
+7 8 (000) 000-00-00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Flavimax Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Aug-2019 Completed Out of Business
1. Early Stage VC Completed Startup
To view Flavimax’s complete valuation and funding history, request access »